Evidence map›Paper›PMID 29577064›Full record

ArticleApplied materials today2018

Functionalization of PCL-3D Electrospun Nanofibrous Scaffolds for Improved BMP2-Induced Bone Formation.

Jacob M Miszuk, Tao Xu, Qingqing Yao, Fang Fang, Josh D Childs, Zhongkui Hong, Jianning Tao, Hao Fong, Hongli Sun

Abstract read
In one paragraph

Article in Applied materials today, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Multifunctional Nanofibrous Hollow Microspheres for Enhanced Periodontal Bone Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  7. Article
  8. Article
  9. Exploring microRNAs in craniofacial regenerative medicine.Biochemical Society transactions · 2023
    Review
  10. Targeting Agents in Biomaterial-Mediated Bone Regeneration.International journal of molecular sciences · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jacob M MiszukDepartment of Biomedical Engineering, University of South Dakota, BioSNTR, Sioux Falls, SD 57107, USA.
Tao XuProgram of Biomedical Engineering, South Dakota School of Mines and Technology, Rapid City, SD 57701, USA.
Qingqing YaoDepartment of Biomedical Engineering, University of South Dakota, BioSNTR, Sioux Falls, SD 57107, USA.
Fang FangChildren's Health Research Center at Sanford Research, Sioux Falls, SD 57104, USA.
Josh D ChildsDepartment of Biomedical Engineering, University of South Dakota, BioSNTR, Sioux Falls, SD 57107, USA.
Zhongkui HongDepartment of Biomedical Engineering, University of South Dakota, BioSNTR, Sioux Falls, SD 57107, USA.
Jianning TaoChildren's Health Research Center at Sanford Research, Sioux Falls, SD 57104, USA.
Hao FongProgram of Biomedical Engineering, South Dakota School of Mines and Technology, Rapid City, SD 57701, USA.
Hongli SunDepartment of Biomedical Engineering, University of South Dakota, BioSNTR, Sioux Falls, SD 57107, USA.

Funding

Yeast 2 HybridP20GM103620 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2023
$24.2M
The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI MISKIMINS, W KEITH · 2012 to 2020
$20.8M
NIGMS NIH HHS P20 GM103548NIGMS NIH HHS P20 GM103620
6 · The paper itself

Abstract

Bone morphogenic protein 2 (BMP2) is a key growth factor for bone regeneration, possessing FDA approval for orthopedic applications. BMP2 is often required in supratherapeutic doses clinically, yielding adverse side effects and substantial treatment costs. Considering the crucial role of materials for BMPs delivery and cell osteogenic differentiation, we devote to engineering an innovative bone-matrix mimicking niche to improve low dose of BMP2-induced bone formation. Our previous work describes a novel technique, named thermally induced nanofiber self-agglomeration (TISA), for generating 3D electrospun nanofibrous (NF) polycaprolactone (PCL) scaffolds. TISA process could readily blend PCL with PLA, leading to increased osteogenic capabilities

Indexed as

3D electrospun nanofibrous scaffoldBone RegenerationHydroxyapatite functionalizationOsteogenic differentiationPhenamil

Identifiers

PMID29577064
PMCPMC5863927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.